Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPT2 | P23786 | 1/20 | 0.38 |
| ▸ | CPT1A | P50416 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | LAP3 | P28838 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | METAP1 | P53582 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8911564 | 0.78 | SLC22A16 (0.38) | CPT2CPT1ALMNACHRM2CHRM4 | |
| SCHEMBL2553127 | 0.76 | SLC22A16 (0.32) | CPT2CPT1ALMNACHRM2CHRM4 | |
| SCHEMBL11347712 | 0.76 | SLC22A16 (0.32) | CPT2CPT1ALMNACHRM2CHRM4 | |
| SCHEMBL192296 | 0.74 | MEN1 (0.39) | LMNATSHRCYP2C9MAPTSLC22A16 | |
| SCHEMBL14739986 | 0.74 | GABBR2 (0.36) | CPT2CPT1ALMNACHRM2CHRM4 | |
| SCHEMBL8910736 | 0.73 | LAP3 (0.37) | CPT2CPT1ALMNACHRM2CHRM4 | |
| SCHEMBL14739090 | 0.72 | MEN1 (0.35) | LMNATSHRCYP2C9MAPTMEN1 | |
| SCHEMBL1692410 | 0.72 | MEN1 (0.37) | LMNATSHRCYP2C9MAPTMEN1 | |
| SCHEMBL29869153 | 0.72 | MEN1 (0.33) | CPT2CPT1ASLC22A16MEN1CYP1A2 | |
| SCHEMBL3503898 | 0.71 | MEN1 (0.34) | LMNAMEN1CYP1A2HRH1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100040712-A1 | THROAT SPRAY | CNS, INC. | 2010-02-18 | — | — | US | claimed |
| EP-2015761-A4 | METHODS AND COMPOSITION FOR TREATING SORE THROAT | NAVEH PHARMA 1996 LTD (IL) | 2009-07-29 | — | — | EP | claimed |
| EP-2015761-A2 | METHODS AND COMPOSITION FOR TREATING SORE THROAT | Naveh Pharma (1996) Ltd. (IL) | 2009-01-21 | — | — | EP | claimed |
| US-20080124411-A1 | nasal strip; and an orally administered composition comprising a tissue-firming agent, a tissue-soothing agent, a tissue lubricant, and an expectorant; for combating snoring | CNS, INC. (US) | 2008-05-29 | — | — | US | claimed |
| WO-2007110871-A2 | METHODS AND COMPOSITION FOR TREATING SORE THROAT | NAVEH PHARMA (1996) LTD. (IL) | 2007-10-04 | — | — | WO | claimed |
| US-20060057227-A1 | Throat spray | CNS, INC. | 2006-03-16 | — | — | US | claimed |
| EP-1513481-A2 | THROAT SPRAY | CNS, Inc. (US) | 2005-03-16 | — | — | EP | claimed |
| WO-2003070178-A2 | THROAT SPRAY | CNS, INC. (US) | 2003-08-28 | — | — | WO | claimed |
| US-8138200-B2 | Compositions and methods for double-targeting virus infections and targeting cancer cells | WAKE FOREST UNIVERSITY (US) | 2012-03-20 | — | — | US | disclosed |
| US-20100184718-A1 | Compositions and Methods for Double-Targeting Virus Infections and Targeting Cancer Cells | WAKE FOREST UNIVERSITY | 2010-07-22 | — | — | US | disclosed |
| US-20100040712-A1 | THROAT SPRAY | CNS, INC. | 2010-02-18 | — | — | US | disclosed |
| US-7638528-B2 | Compositions and methods for targeting cancer cells | WAKE FOREST UNIVERSITY SCHOOL OF MEDICINE (US) | 2009-12-29 | — | — | US | disclosed |
| EP-2015761-A4 | METHODS AND COMPOSITION FOR TREATING SORE THROAT | NAVEH PHARMA 1996 LTD (IL) | 2009-07-29 | — | — | EP | disclosed |
| EP-2015761-A2 | METHODS AND COMPOSITION FOR TREATING SORE THROAT | Naveh Pharma (1996) Ltd. (IL) | 2009-01-21 | — | — | EP | disclosed |
| US-20020082242-A1 | Compositions and methods of double-targeting virus infections and cancer cells | WAKE FOREST UNIVERSITY SCHOOL OF MEDICINE | 2002-06-27 | — | — | US | disclosed |
| US-6329352-B1 | APPLYING PULMONARY ALVEOLAR SURFACTANT BEFORE SLEEP | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2001-12-11 | — | — | US | disclosed |
| WO-2001034614-A2 | COMPOSITIONS AND METHODS FOR DOUBLE-TARGETING VIRUS INFECTIONS AND TARGETING CANCER CELLS | WAKE FOREST UNIVERSITY (US) | 2001-05-17 | — | — | WO | disclosed |
| EP-1009411-A1 | METHOD AND COMPOSITION FOR TREATING SLEEP APNEA | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2000-06-21 | — | — | EP | disclosed |
| US-5958902-A | APPLYING A PULMONARY ALVEOLAR SURFACTANT PREPARATION IN A PHARMACOLOGICALLY EFFECTIVE DOSE TO THE POSTERIOR PHARYNGEAL REGION OF A PATIENT PRIOR TO A PERIOD OF SLEEP. | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1999-09-28 | — | — | US | disclosed |
| WO-1998046245-A1 | METHOD AND COMPOSITION FOR TREATING SLEEP APNEA | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1998-10-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020082242-A1 | Compositions and methods of double-targeting virus infections and cancer cells | PHOSPHO1, PIGS, SMPD1 | CPT2 1161/4885CPT1A 985/4885LMNA 870/4885 |
| US-20100184718-A1 | Compositions and Methods for Double-Targeting Virus Infections and Targeting Cancer Cells | PHOSPHO1, PIGS, SMPD1 | CPT2 1013/4885CPT1A 1050/4885LMNA 734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.